- Recruiting
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
This study looks at how people with a heart condition called obstructive hypertrophic cardiomyopathy (HCM) are treated in real life. It compares a new medicine called mavacamten with other treatments, focusing on how patients feel and how their condition progresses over time.
For: Obstructive Hypertrophic CardiomyopathyUnited States · Austria · France - Active not recruitingPHASE3
A Study to Evaluate Mavacamten in Adolescents With Symptomatic Obstructive Hypertrophic Cardiomyopathy
This study is looking into a new medicine called mavacamten for teenagers (12-17 years old) with a heart condition called hypertrophic cardiomyopathy (HCM). It aims to see how well it works, if it's safe, and how the body handles it, to help improve symptoms.
For: Cardiomyopathy, HypertrophicUnited States · Australia · Canada - Active not recruitingPHASE4
A Study to Evaluate Mavacamten Impact on Myocardial Structure in Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy
This study looks at how a new medicine, mavacamten, affects the heart's structure in adults with a specific heart condition called hypertrophic cardiomyopathy. We'll use special MRI scans to see these changes, aiming to better understand the treatment's impact.
For: Cardiomyopathy, HypertrophicUnited States · Argentina · Australia - Active not recruiting
A Retrospective Cohort Study of Mavacamten Patient Support Program in Canada
This study looks back at information from Canadian adults with a heart condition called hypertrophic cardiomyopathy who used the medicine mavacamten. It helps us understand more about these patients and how they used the medicine through a special support programme.
For: Hypertrophic CardiomyopathyCanada - Recruiting
Mavacamten Outcomes in Hypertrophic Cardiomyopathy (HCM) and the Associated Patient and Physician Experiences in the US
This study looks at how a medicine called mavacamten works for adults with a heart condition called obstructive hypertrophic cardiomyopathy (oHCM). It aims to understand patients' and doctors' experiences with this treatment in the US.
For: Obstructive Hypertrophic Cardiomyopathy (oHCM)United Kingdom